Search

Lavanya Sagi

from Parsippany, NJ
Age ~49
Get Report
Also known as:
Suresh V Sagi
Related to:
Suresh V Sagi, 49
Connected to:
Asaf Sagi, 45Gayatri S Sagi, 41Kavitha Sagi, 45Martha E Sagi, 77Rubin Sagi, 48Shimonovitz Sagi, 55Zohar Sagi, 50Alon Sagie, 60Jill R Sagiia, 60Michael J Sagin, 30

Lavanya Sagi Phones & Addresses

  • Parsippany, NJ
  • 6875 Peachtree Dunwoody Rd, Atlanta, GA 30328 (678) 691-8912 (770) 399-1964
  • Cumming, GA
  • 1480 Us Highway 46 APT 407B, Parsippany, NJ 07054

Resumes

Resumes

Lavanya Sagi Photo 1

Project Management

View page
Location:
Parsippany, NJ
Industry:
Research
Work:
Novartis since Aug 2009
Scientist
Reddy US Therapeutics, INC Mar 2003 - Jul 2009
scientist
Dr. Reddy's Laboratories Aug 1999 - Feb 2003
officer
Education:
Osmania University 1997 - 1999
Masters, Medicinal chemistry Osmania University 1997 - 1999
Masters, Medicinal chemsitry
Skills:
Pharmaceutical Industry
Hplc
Drug Discovery
Dissolution
Gmp
Glp
Analytical Chemistry
Technology Transfer
Validation
Formulation
Uv/Vis
Regulatory Affairs
Languages:
Hindi
Lavanya Sagi Photo 2

Lavanya Sagi

View page

Publications

Us Patents

Novel Pyridine Compounds, Process For Their Preparation And Compositions Containing Them

View page
US Patent:
20060084644, Apr 20, 2006
Filed:
Sep 23, 2005
Appl. No.:
11/234257
Inventors:
Manojit Pal - Hyderabad, IN
Christopher Alexander - Atlanta GA, US
Ish Khanna - Alpharetta GA, US
Javed Iqbal - Hyderabad, IN
Ram Pillarisetti - Norcross GA, US
Santanu Maitra - Hyderabad, IN
Gayla Roberts - Atlanta GA, US
Lavanya Sagi - Atlanta GA, US
Chintakunta Krishna - Hyderabad, IN
Jennepalli Sreenu - Hyderabad, IN
International Classification:
A61K 31/541
A61K 31/5377
A61K 31/496
A61K 31/4545
A61K 31/4439
A61K 31/44
C07D 417/02
C07D 403/02
C07D 413/02
C07D 401/02
US Classification:
514227500, 514235200, 514253010, 514318000, 514343000, 514352000, 544060000, 544124000, 544360000, 546194000, 546276400, 546304000
Abstract:
The present invention provides new heterocyclic compounds, particularly substituted pyridines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.
Control profile
Lavanya Sagi from Parsippany, NJ, age ~49 Get Report